Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002054 · ClinicalTrials.gov registry record · NA
A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients
A NA study, sponsored by Fisons.
- Completed
- Registry status
- NA
- Development phase
NCT00002054: Completed NA study, sponsored by Fisons.
NCT00002054 is a NA study that has completed, run by Fisons. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002054, a NA study, has completed, sponsored by Fisons.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate the safety, tolerability, and description of time to Pneumocystis carinii pneumonia (PCP) for long-term biweekly administration of 1 of 2 doses of aerosol pentamidine when used as a prophylactic agent in patients who have had one episode of AIDS-associated PCP.
Interventions
- DRUG Pentamidine isethionate
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002054 record still lists
NCT00002054 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Pentamidine isethionate is the first listed.
NCT00002054 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002054 about?
NCT00002054 is a clinical study titled "A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients". To evaluate the safety, tolerability, and description of time to Pneumocystis carinii pneumonia (PCP) for long-term biweekly administration of 1 of 2 doses of aerosol pentamidine when used as a prophylactic agent in patients who have had one episode of AIDS-associated PCP.
What is the current status of trial NCT00002054?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002054?
The interventions under investigation include: Pentamidine isethionate (DRUG).
Who is sponsoring clinical trial NCT00002054?
This trial is sponsored by Fisons, which has 5 total clinical trials registered on ClinicalTrials.gov.